Pharmaceutical Technology
JUNE 4, 2024
A June 2024 literature review has revealed that climate change has the potential to intensify MS symptoms, as well as the incidence, prevalence, and severity of other major neurological disorders.
Bio Pharma Dive
JUNE 4, 2024
A group of independent experts wasn't convinced by clinical trial data from company Lykos Therapeutics, which is seeking FDA approval of MDMA-assisted treatment for post-traumatic stress disorder.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 4, 2024
Scientists at the NIH have introduced an AI tool to predict the response to immune checkpoint inhibitors for cancer patients.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 4, 2024
Though one in two people will develop some form of cancer in their lifetime, there’s still much we don’t know about this disease. But thanks to continued research efforts, we keep learning more about the biology of cancer. One of these recent discoveries could even transform our understanding of how cancers develop.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JUNE 4, 2024
Alligator Bioscience’s CEO says that its pancreatic cancer drug may mark a meaningful improvement on current treatment standards.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 4, 2024
With the effective implementation of its flagship e-governance programme, Gujarat Food and Drug Control Administration (FDCA)’s online WHO-GMP certificate verification is all poised to boost pharma exports, informs Gujarat FDCA commissioner Dr H G Koshia. Good Manufacturing Practice (GMP) is a critical concept in the pharmaceutical industry.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
JUNE 4, 2024
Longer follow-up results from a mid-stage trial indicate the company’s treatment for a genetic cause of dwarfism may be competitive to an approved therapy from BioMarin Pharmaceutical.
Pharmaceutical Technology
JUNE 4, 2024
EryDex is being evaluated in the Phase III NEAT study which will enrol over 100 patients with rare disease ataxia-telangiectasia.
Bio Pharma Dive
JUNE 4, 2024
The company may look to license the experimental liver disease drug as it focuses on an obesity treatment that's shown early promise.
Pharmaceutical Technology
JUNE 4, 2024
Monday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE) following a Delaware judge’s ruling on 31 May that over 72,000 lawsuits over discontinued heartburn drug Zantac, known generically as ranitidine, could go ahead.
Bio Pharma Dive
JUNE 4, 2024
One analyst said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for years to come.
Fierce Pharma
JUNE 4, 2024
A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has retu | A little less than a year after Eli Lilly won the blessing of England's drug value watchdog for tirzepatide in Type 2 diabetes, the National Institute for Health and Care Excellence (NICE) has returned with an endorsement in obesity.
Pharmaceutical Technology
JUNE 4, 2024
Discover key considerations for selecting pharmaceutical waist containers. Find out about the latest technology used in pharmaceutical closure systems.
Fierce Pharma
JUNE 4, 2024
For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party (CCP) has continued to gain steam. | For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party has continued to gain steam. Now, several new names could be feeling the heat.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JUNE 4, 2024
At the ASCO conference, investigators highlighted the potential of Moderna’s cancer vaccine combination based on Phase II data.
pharmaphorum
JUNE 4, 2024
ViVE conference highlights the key takeaways on artificial intelligence, cybersecurity concerns, and industry transactions. Stay updated on the latest trends and partnerships shaping these fields.
Pharmaceutical Technology
JUNE 4, 2024
The BIOSECURE Act could impact more than 120 US biopharmaceutical drugs in development by companies partnered with Chinese contract development and manufacturing organisations (CDMOs) and biotechnology companies.
pharmaphorum
JUNE 4, 2024
Discover the latest advancements in life sciences R&D and quality at the Veeva R&D Quality Summit at the Marriott Auditorium Hotel in Madrid. Join industry leaders as they discuss the importance of a single source of truth.
Pharmaceutical Technology
JUNE 4, 2024
The EMA CHMP has recommended approval for AstraZeneca's Tagrisso for the first-line treatment of non-small cell lung cancer (NSCLC).
Pharma Times
JUNE 4, 2024
Positive clinical data from phase 1 study presented at ASCO annual meeting
Pharmaceutical Technology
JUNE 4, 2024
Aurigene Pharmaceutical, a Dr Reddy's Laboratories unit, has opened a biologics facility at Genome Valley in the Indian city of Hyderabad.
pharmaphorum
JUNE 4, 2024
Get insights into the exclusive interview with Mohit Manrao, AstraZeneca SVP and Head of Oncology. Explore the highlights of the conversation and ASCO 2024 here.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JUNE 4, 2024
Philogen and Sun Pharma have sought EMA approval for Nidlegy to treat locally advanced, fully resectable melanoma.
pharmaphorum
JUNE 4, 2024
Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and analysts think uptake by patients is now poised to take off.
Fierce Pharma
JUNE 4, 2024
After Amarin's tussle with investor group Sarissa Capital led to a restructuring and a board shuffle, the struggling drugmaker is undergoing its third CEO shake-up in just over a year.
pharmaphorum
JUNE 4, 2024
New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
JUNE 4, 2024
In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. In this Xtalks Spotlight feature, Oren Cohen, MD, Chief Medical Officer (CMO) and President of Clinical Pharmacology at Fortrea shared insights into these challenges and the strategies Fortrea employs to manage them efficiently.
pharmaphorum
JUNE 4, 2024
Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineffective. To plug that gap, Germany’s Bayer has joined forces with electronics group Samsung to carry out an observational study on sleep disturbances during menopause (SDM), tapping into the South Korean company’s position as one of the world's largest producers of consumer electronics.
Fierce Pharma
JUNE 4, 2024
An Oregon jury has awarded $260 million to a woman who claimed that use of Johnson and Johnson's talc products caused her mesothelioma.
pharmaphorum
JUNE 4, 2024
FDA advisors voted against the use of Lykos Therapeutics’ MDMA-based therapy for PTSD, in a first regulatory test for the emerging psychedelics sector
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
246 
Let's personalize your content